Imad Al-Dakkak - Alexion, AstraZeneca Rare Disease

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

#243 Characteristics and Safety in Patients with Atypical Haemolytic Uraemic Syndrome Switching to Ravulizumab from Eculizumab: a Global Registry Analysis

Franz Schaefer,Imad Al-Dakkak,Nuria Saval,David Cohen,Laurence A. Greenbaum,Gema Ariceta

NEPHROLOGY DIALYSIS TRANSPLANTATION (2024): I18-I20

引用0浏览0引用

Global Ahus Registry Analysis of Patients Switching to Ravulizumab from Eculizumab

Franz Schaefer,Imad Al-Dakkak,Katerina Anokhina,David Cohen,Larry A. Greenbaum,Gema Ariceta

KIDNEY INTERNATIONAL REPORTSno. 9 (2024): 2648-2656

引用0浏览0WOS引用

Characterization of Patients with Ahus and Associated Triggers or Clinical Conditions: A Global Ahus Registry Analysis

Christoph Licht,Imad Al-Dakkak,Katerina Anokhina,Nicole Isbel,Veronique Fremeaux-Bacchi,Rodney D. Gilbert,Larry A. Greenbaum,Gema Ariceta,Gianluigi Ardissino,Franz Schaefer,Eric Rondeau

Nephrology (2024)

引用0浏览0WOS引用

Clinical characteristics and outcome of patients with atypical Hemolytic Uremic Syndrome: Belgian cohort of the global aHUS registry

Johan Vande Walle,Laurent Weekers,Kathleen Claes,Nilufer Broeders,Evelien Snauwaert,Djalila Mekahli,Eric Goffin,Laure Collard,Nathalie Godefroid,Brigitte Adams, Karen Vanhaute,Koenraad Van Hoeck,Johann Morelle,Dirk Kuypers, Lara Zonnekein,Imad Al-Dakkak,Karin Dahan,Patrick Stordeur,Annick Massart

PEDIATRIC NEPHROLOGY (2023): 15-15

引用0浏览0引用

Atypical Hemolytic Uremic Syndrome Treated with Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States

Yan Wang,Imad Al-Dakkak,Katherine Garlo,Moh-Lim Ong,Ioannis Tomazos,Arash Mahajerin

KIDNEY MEDICINEno. 8 (2023)

引用0浏览0WOS引用

#3074 changes in the clinical characteristics and management of patients with ahus over 10 years: trends from the global ahus registry

Andrew Siedlecki,Imad Al-Dakkak,Katerina Anokhina,Gema Ariceta,Gianluigi Ardissino,Laurence A. Greenbaum,Christoph Licht,Johan Van de Walle

Nephrology Dialysis Transplantationno. Supplement_1 (2023)

引用0浏览0引用

FC 115: Long-Term Outcomes in Eculizumab-Treated Kidney Transplant Patients Enrolled in the Global Atypical Haemolytic Uraemic Syndrome Registry

Maria Gema Ariceta Iraola,Imad Al-Dakkak,Katerina Anokhina,Gianluigi Ardissino,Laurence A. Greenbaum,Gurinder Kumar,Christoph Licht,Andrew Siedlecki,Johan Van de Walle

Nephrology, dialysis, transplantation/Nephrology dialysis transplantation（2022）

引用0浏览0引用

Characterization of Patients with Ahus and Triggering/Associated Events, with and Without Complement Pathogenic Variants or Anti-Cfh Antibodies: A Global Ahus Registry Analysis

Andrew Siedlecki,Imad Al-Dakkak,Katerina Anokhina,Nicole Isbel,Veronique Fremeaux-Bacchi,Rodney Gilbert,Laurence Greenbaum,Gema Ariceta,Gianluigi Ardissino,Franz Schaefer,Eric Rondeau,Christoph Licht

Journal of the American Society of Nephrology（2022）

引用3浏览0引用

Clinical Characteristics and Outcomes of a Patient Population with Atypical Hemolytic Uremic Syndrome and Malignant Hypertension: Analysis from the Global Ahus Registry

Halimi Jean-Michel,Al-Dakkak Imad,Anokhina Katerina,Ardissino Gianluigi,Licht Christoph,Lim Wai H.,Massart Annick,Schaefer Franz,Walle Johan Vande,Rondeau Eric

JN Journal of Nephrology（2022）

引用2浏览0WOS引用

Long-Term Outcomes in Eculizumab-Treated Patients Enrolled in the Global aHUS Registry

Larry A. Greenbaum,Imad Al-Dakkak, Ekaterina Anokhina,Gianluigi Ardissino,Gema Ariceta,Gurinder Kumar,Christoph Licht,Andrew M. Siedlecki,Johan Vande walle

Journal of the American Society of Nephrologyno. 11S (2022): 189-189

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn